Cyfra 21-1 and TPA as markers in malignant mesothelioma

被引：0
作者：
Bonfrer, JMG
Schouwink, JH
Korse, CM
Baas, P
机构：
[1] OLVG HOSP,DEPT PULMONOL,NL-1091 HA AMSTERDAM,NETHERLANDS
[2] NETHERLANDS CANC INST,ANTONI VAN LEEUWENHOEK HUIS,DEPT MED ONCOL,NL-1066 CX AMSTERDAM,NETHERLANDS
来源：
ANTICANCER RESEARCH | 1997年 / 17卷 / 4B期
关键词：
Cyfra; 21-1; TPA; malignant mesothelioma;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Background: Serum concentrations of CEA and Cyfra were compared in patients with mesothelioma. Materials and Methods: Serum levels of patients were analysed for prognosis of survival and follow up of disease. Results: Cyfra 21-1 and TPA have significant prognostic value for survival. Conclusion: Assays measuring CK19 fragments seem to be good markers in the management of patients with malignant mesothelioma.
引用
收藏
页码：2971 / 2973
页数：3
相关论文
共 7 条
[1]  
BODENMUELLER H, 1992, Proceedings of the American Association for Cancer Research Annual Meeting, V33, P203
[2]   THE CATALOG OF HUMAN CYTOKERATINS - PATTERNS OF EXPRESSION IN NORMAL EPITHELIA, TUMORS AND CULTURED-CELLS [J].
MOLL, R ;
FRANKE, WW ;
SCHILLER, DL ;
GEIGER, B ;
KREPLER, R .
CELL, 1982, 31 (01) :11-24
[3]   CONTINUING INCREASE IN MESOTHELIOMA MORTALITY IN BRITAIN [J].
PETO, J ;
HODGSON, JT ;
MATTHEWS, FE ;
JONES, JR .
LANCET, 1995, 345 (8949) :535-539
[4]  
PUJOL JL, 1993, CANCER RES, V53, P61
[5]   CYFRA-21-1, A SENSITIVE AND SPECIFIC NEW TUMOR-MARKER FOR SQUAMOUS-CELL LUNG-CANCER - REPORT OF THE FIRST EUROPEAN MULTICENTER EVALUATION [J].
RASTEL, D ;
RAMAIOLI, A ;
CORNILLIE, F ;
THIRION, B .
EUROPEAN JOURNAL OF CANCER, 1994, 30A (05) :601-606
[6]   DEVELOPMENT OF A NEW PROLIFIGEN TPA IRMA ASSAY USING MONOCLONAL ANTI-CYTOKERATIN ANTIBODIES [J].
SUNDSTROM, BE ;
DAMICO, Y ;
BRUNDELL, J .
INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 1995, 10 (03) :166-173
[7]  
WAGNER J C, 1960, Br J Ind Med, V17, P260
1